John D Quisel Insider Trading $XLRN ACCELERON PHARMA INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for John D Quisel.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of John D Quisel. John D Quisel is EVP, CBO and Secretary in ACCELERON PHARMA INC ($XLRN) and EVP, Chief Business Officer in ACCELERON PHARMA INC ($XLRN) and SVP Gen. Counsel & Secretary in ACCELERON PHARMA INC ($XLRN) and SVP, Bus. Dev., GC & Secretary in ACCELERON PHARMA INC ($XLRN) and SVP, Corp. Dev., GC & Sec. in ACCELERON PHARMA INC ($XLRN) and VP General Counsel & Secretary in ACCELERON PHARMA INC ($XLRN).
John D Quisel in ACCELERON PHARMA INC
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of John D Quisel: EVP, Chief Business Officer, EVP, CBO and Secretary, SVP, Corp. Dev., GC & Sec., SVP, Bus. Dev., GC & Secretary, SVP Gen. Counsel & Secretary, VP General Counsel & Secretary
Holdings: 57,558 shares
Current Value: $1,366,427
Latest Transaction: Jan 03 2020
$XLRN Market Capitalization: $879.48M
$XLRN Previous Close: $23.74
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of John D Quisel in ACCELERON PHARMA INC
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 16 2014 | XLRN | ACCELERON PHARMA I ... | Quisel John D | SVP Gen. Counsel & ... | Sell | S | 30.12 | 3,000 | 90,360 | 0 | 3 K to 0 (-100.00 %) |
| Jul 16 2014 | XLRN | ACCELERON PHARMA I ... | Quisel John D | SVP Gen. Counsel & ... | Buy | M | 5.28 | 3,000 | 15,840 | 3,000 | 0 to 3 K |
| Jul 16 2014 | XLRN | ACCELERON PHARMA I ... | Quisel John D | SVP Gen. Counsel & ... | Sell | S | 29.71 | 900 | 26,739 | 0 | 900 to 0 (-100.00 %) |
| Jul 16 2014 | XLRN | ACCELERON PHARMA I ... | Quisel John D | SVP Gen. Counsel & ... | Sell | S | 28.70 | 1,100 | 31,570 | 900 | 2 K to 900 (-55.00 %) |
| Jul 16 2014 | XLRN | ACCELERON PHARMA I ... | Quisel John D | SVP Gen. Counsel & ... | Buy | M | 0.92 | 2,000 | 1,840 | 2,000 | 0 to 2 K |
| Jul 02 2014 | XLRN | ACCELERON PHARMA I ... | Quisel John D | SVP Gen. Counsel & ... | Option Exercise | A | 34.05 | 10,000 | 340,500 | 10,000 | |
| Jun 17 2014 | XLRN | ACCELERON PHARMA I ... | Quisel John D | VP General Counsel ... | Option Exercise | M | 5.28 | 2,740 | 14,467 | 16,010 | |
| Jun 17 2014 | XLRN | ACCELERON PHARMA I ... | Quisel John D | VP General Counsel ... | Option Exercise | M | 3.88 | 4,260 | 16,529 | 51,240 | |
| Jun 17 2014 | XLRN | ACCELERON PHARMA I ... | Quisel John D | VP General Counsel ... | Option Exercise | M | 0.92 | 2,000 | 1,840 | 21,500 | |
| Jun 17 2014 | XLRN | ACCELERON PHARMA I ... | Quisel John D | VP General Counsel ... | Sell | S | 34.13 | 2,700 | 92,151 | 0 | 2.7 K to 0 (-100.00 %) |
| Jun 17 2014 | XLRN | ACCELERON PHARMA I ... | Quisel John D | VP General Counsel ... | Sell | S | 33.86 | 6,300 | 213,318 | 2,700 | 9 K to 2.7 K (-70.00 %) |
| Jun 17 2014 | XLRN | ACCELERON PHARMA I ... | Quisel John D | VP General Counsel ... | Buy | M | 5.28 | 2,740 | 14,467 | 9,000 | 6.3 K to 9 K (+43.77 %) |
| Jun 17 2014 | XLRN | ACCELERON PHARMA I ... | Quisel John D | VP General Counsel ... | Buy | M | 3.88 | 4,260 | 16,529 | 6,260 | 2 K to 6.3 K (+213.00 %) |
| Jun 17 2014 | XLRN | ACCELERON PHARMA I ... | Quisel John D | VP General Counsel ... | Buy | M | 0.92 | 2,000 | 1,840 | 2,000 | 0 to 2 K |
| May 21 2014 | XLRN | ACCELERON PHARMA I ... | Quisel John D | VP General Counsel ... | Option Exercise | M | 3.88 | 7,000 | 27,160 | 55,500 | |
| May 21 2014 | XLRN | ACCELERON PHARMA I ... | Quisel John D | VP General Counsel ... | Option Exercise | M | 0.92 | 2,000 | 1,840 | 23,500 | |
| May 21 2014 | XLRN | ACCELERON PHARMA I ... | Quisel John D | VP General Counsel ... | Sell | S | 32.20 | 900 | 28,980 | 0 | 900 to 0 (-100.00 %) |
| May 21 2014 | XLRN | ACCELERON PHARMA I ... | Quisel John D | VP General Counsel ... | Sell | S | 31.29 | 6,100 | 190,869 | 900 | 7 K to 900 (-87.14 %) |
| May 21 2014 | XLRN | ACCELERON PHARMA I ... | Quisel John D | VP General Counsel ... | Buy | M | 3.88 | 7,000 | 27,160 | 7,000 | 0 to 7 K |
| May 21 2014 | XLRN | ACCELERON PHARMA I ... | Quisel John D | VP General Counsel ... | Sell | S | 31.49 | 2,000 | 62,980 | 0 | 2 K to 0 (-100.00 %) |
| May 21 2014 | XLRN | ACCELERON PHARMA I ... | Quisel John D | VP General Counsel ... | Buy | M | 0.92 | 2,000 | 1,840 | 2,000 | 0 to 2 K |
| Apr 24 2014 | XLRN | ACCELERON PHARMA I ... | Quisel John D | VP General Counsel ... | Option Exercise | M | 0.92 | 2,000 | 1,840 | 25,500 | |
| Apr 24 2014 | XLRN | ACCELERON PHARMA I ... | Quisel John D | VP General Counsel ... | Sell | S | 36.13 | 500 | 18,065 | 0 | 500 to 0 (-100.00 %) |
| Apr 24 2014 | XLRN | ACCELERON PHARMA I ... | Quisel John D | VP General Counsel ... | Sell | S | 35.75 | 1,500 | 53,625 | 500 | 2 K to 500 (-75.00 %) |
| Apr 24 2014 | XLRN | ACCELERON PHARMA I ... | Quisel John D | VP General Counsel ... | Buy | M | 0.92 | 2,000 | 1,840 | 2,000 | 0 to 2 K |
| Dec 09 2013 | XLRN | ACCELERON PHARMA I ... | Quisel John D | VP General Counsel ... | Option Exercise | A | 24.11 | 29,000 | 699,190 | 29,000 |